Swiss National Bank’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,763
| Closed | -$112K | – | 2552 |
|
|
2023
Q3 | $112K | Hold |
2,763
| – | – | ﹤0.01% | 2608 |
|
|
2023
Q2 | $294K | Buy |
2,763
+119
| +5% | +$12.7K | ﹤0.01% | 2593 |
|
|
2023
Q1 | $789K | Sell |
2,644
-250
| -9% | -$74.6K | ﹤0.01% | 2374 |
|
|
2022
Q4 | $995K | Hold |
2,894
| – | – | ﹤0.01% | 2347 |
|
|
2022
Q3 | $547K | Hold |
2,894
| – | – | ﹤0.01% | 2537 |
|
|
2022
Q2 | $611K | Hold |
2,894
| – | – | ﹤0.01% | 2562 |
|
|
2022
Q1 | $968K | Buy |
2,894
+244
| +9% | +$81.6K | ﹤0.01% | 2419 |
|
|
2021
Q4 | $862K | Hold |
2,650
| – | – | ﹤0.01% | 2528 |
|
|
2021
Q3 | $1.29M | Hold |
2,650
| – | – | ﹤0.01% | 2313 |
|
|
2021
Q2 | $1.23M | Buy |
2,650
+562
| +27% | +$261K | ﹤0.01% | 2382 |
|
|
2021
Q1 | $1.44M | Buy |
2,088
+194
| +10% | +$134K | ﹤0.01% | 2189 |
|
|
2020
Q4 | $1.4M | Sell |
1,894
-206
| -10% | -$152K | ﹤0.01% | 2125 |
|
|
2020
Q3 | $1.46M | Buy |
2,100
+687
| +49% | +$477K | ﹤0.01% | 1874 |
|
|
2020
Q2 | $1.2M | Buy |
+1,413
| New | +$1.2M | ﹤0.01% | 2003 |
|